You are currently viewing a new version of our website. To view the old version click .

The Development and Severity of Infectious Uveitis

This special issue belongs to the section “Antibiotic Therapy in Infectious Diseases“.

Special Issue Information

Dear Colleagues,

Infections are a leading cause of ocular inflammation worldwide. By exogenous or endogenous transmission, a wide variety of pathogens including bacteria, viruses, fungi, and parasites can cause infectious uveitis. While certain entities such as toxoplasmosis, syphilis, and tuberculosis comprise the majority of cases of intraocular inflammation, other emerging pathogens have also been shown to cause uveitis. The development of infectious uveitis can range from rapidly progressive fulminant infection to a chronic, indolent course. Diagnosis of intraocular infections can be challenging and multiple factors may lead to significant ocular morbidity including delay in diagnosis, drug-resistant infections, and concomitant inflammation, which can destroy ocular tissues. This Special Issue seeks manuscripts on the pathogenesis, severity, diagnosis, and management of infectious uveitis with a special focus on clinical presentation and management challenges, new diagnostic testing modalities, and antimicrobial drug delivery options.

Dr. Ann Marie Lobo
Dr. Pooja Bhat
Dr. Tejabhiram Yadavalli
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • infectious uveitis
  • endophthalmitis
  • intravitreal antibiotics
  • ocular syphilis
  • ocular tuberculosis
  • diagnostic testing
  • epidemiology

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Published Papers

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Antibiotics - ISSN 2079-6382